These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 12534147

  • 1. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM, Katyal A.
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [Abstract] [Full Text] [Related]

  • 2. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 3. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 4. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 5. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 May 07; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 6. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 8. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 9. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 25; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 10. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.
    Chuang P, Langone AJ.
    Am J Ther; 2007 Dec 25; 14(5):438-41. PubMed ID: 17890931
    [Abstract] [Full Text] [Related]

  • 11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 25; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 12. I have had trouble controlling my cholesterol with a statin alone. Should I consider prescription niacin?
    Johns Hopkins Med Lett Health After 50; 2010 Feb 25; 21(12):8. PubMed ID: 20344817
    [No Abstract] [Full Text] [Related]

  • 13. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 25; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 14. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors.
    Langone AJ, Chuang P.
    Transplantation; 2006 Mar 15; 81(5):804-7. PubMed ID: 16534487
    [Abstract] [Full Text] [Related]

  • 15. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 15; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 16. Controlling cholesterol with drugs.
    Stoy DB.
    Am J Nurs; 1989 Dec 15; 89(12):1628-31. PubMed ID: 2589420
    [No Abstract] [Full Text] [Related]

  • 17. [Combination therapy of hypercholesterolemia].
    Vanhanen H, Gylling H, Miettinen TA.
    Duodecim; 2002 Dec 15; 118(19):1967-73. PubMed ID: 12462803
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.
    Indian Heart J; 2008 Dec 15; 60(3):215-22. PubMed ID: 19240310
    [Abstract] [Full Text] [Related]

  • 19. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov 15; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

  • 20. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Martens LL, Rutten FF, Kuijpens JL, Winter J.
    Ned Tijdschr Geneeskd; 1991 Apr 13; 135(15):655-9. PubMed ID: 1903849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.